Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDC Pharmaceutical is a China-based manufacturer of active pharmaceutical ingredients and health-related raw materials, with a business centered on biochemically derived APIs for pharmaceutical and nutritional markets. The company operates GMP-compliant manufacturing and is known for products including heparin sodium, chondroitin sulfate sodium, dermatan sulfate, pancreatin, defibrase, and lactic acid. Publicly available sources indicate the company has regulatory filings such as US DMF and CEP/COS listings for some products and supplies both domestic and international customers. Rather than developing a disclosed therapeutic pipeline, the company appears to focus on commercial production, export, and supply of API and related bulk ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MDC Pharmaceutical.